C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media

Area of Science:

• Immunology
• Cell Biology
• Otolaryngology

Background:

• Otitis media (OM), a common childhood illness, involves innate immunity and tissue growth.
• CJUN terminal kinase (JNK) signaling is implicated in both OM pathogenesis and tissue repair.
• Understanding JNK's role is key to developing targeted OM therapies.

Purpose of the Study:

• To investigate the specific roles of JNK1 and JNK2 isoforms in the context of otitis media.
• To elucidate how JNK signaling impacts mucosal hyperplasia and neutrophil response during middle ear infection.
• To determine the necessity of JNK isoforms for bacterial clearance and recovery from OM.

Main Methods:

• Gene expression analysis of JNK-related pathways in OM.
• Comparative study of wildtype (WT) mice and JNK1/JNK2 deficient mice (JNK1-/- and JNK2-/-).
• Assessment of mucosal thickening, neutrophil recruitment, bacterial load, and recovery timelines in mouse models of OM.

Main Results:

• Genes mediating JNK activation via innate immunity and growth factors are upregulated in OM.
• JNK1 deficiency led to increased mucosal thickening, early neutrophil influx, and delayed bacterial clearance.
• JNK2 deficiency resulted in delayed mucosal hyperplasia, reduced early neutrophil recruitment, and impaired bacterial clearance.

Conclusions:

• JNK1 and JNK2 exhibit opposing functions in early OM mucosal hyperplasia and neutrophil recruitment.
• Both JNK1 and JNK2 are essential for the effective resolution of middle ear infections.
• Differential roles of JNK isoforms highlight potential therapeutic targets for OM treatment.